Skip to main content

Table 3 A multivariate analysis for survival after the first recurrence

From: The mode of progressive disease affects the prognosis of patients with metastatic breast cancer

Factors Hazard ratio 95% CI p value
New lesions at second chemotherapy 1.02 0.54–1.93 0.95
ER (+) 0.28 0.16–0.48 < 0.01
Targeted therapy alone 0.27 0.12–0.62 < 0.01
Eribulin administration 0.49 0.24–0.99 < 0.05
Visceral metastasis at first recurrence 1.10 0.70–1.73 0.68
  1. ER: estrogen receptor